Quantcast

Latest Antibiotic-resistant bacteria Stories

2014-09-17 08:30:09

CHICAGO, Sept. 17, 2014 /PRNewswire-USNewswire/ -- "MRSA is the number one pathogen that is killing patients in U.S. healthcare facilities and continues to spread in the community," states Jeanine R. Thomas, founder of MRSA Survivors Network and the national spokesperson. Methicillin- resistant Staphylococcus aureus (MRSA) and antibiotic resistance must be a top political priority. Join us in the fight against MRSA and antibiotic resistance at the Six Annual World MRSA Day and...

2014-09-15 23:04:23

Clearstream officials comment on this growing health threat – MRSA and the growing list of infections that abound in hospitals nationwide, which Clearstream maintains can be reduced with advanced long-term static antimicrobial technology joined with the screening of hospital patients, staff and visitors. Harrisburg, NC (PRWEB) September 15, 2014 Studies have shown that nationwide, nearly two million people contract infections in hospitals every year, and roughly 100,000 die from them...

2014-09-11 08:27:38

-- Conference Call Scheduled for Friday, September 12, 2014, at 9:15 a.m. EDT -- ROCKVILLE, Md., Sept. 11, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host a an investor conference call on Friday, September 12, 2014, at 9:15 a.m. EDT. The conference call will highlight...

2014-09-07 08:20:25

ROCKVILLE, Md., Sept. 7, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today preclinical data that further validate the Company's novel approach to preventing Clostridium difficile (C. difficile). The U.S. Centers for Disease Control has identified C. difficile as an "urgent public health threat," and it...

2014-09-04 23:10:55

Significant Surgical Site Infection Reduction Demonstrated Vancouver, Canada (PRWEB) September 04, 2014 Results of the first large-scale deployment of Ondine Biomedical’s MRSAid™ Nasal Photodisinfection System demonstrating reduction of surgical site infection rates have been published in the Journal of Hospital Infection (http://www.journalofhospitalinfection.com/article/S0195-6701(14)00224-2/abstract ).    The system was deployed at The Vancouver General...

2014-09-03 16:25:49

LONDON, Sept. 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Antibiotics, medicinal plants, superbugs and the coming antimicrobial resistant drugs pandemic : global markets, competitors and opportuninites - 2014 - 2019 Analysis and...

2014-09-03 08:32:42

ROCKVILLE, Md., Sept. 3, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that Jeffrey Riley, CEO, is scheduled to present at the 16(th) Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. Mr. Riley is scheduled to present at 10:25 a.m. (Eastern Time) on Tuesday,...

Research Sniffs Out Smell Of Disease In Feces
2014-09-02 03:10:38

University of Leicester A fast-sensitive "electronic-nose" for sniffing the highly infectious bacteria C. diff, that causes diarrhea, temperature and stomach cramps, has been developed by a team at the University of Leicester. Using a mass spectrometer, the research team has demonstrated that it is possible to identify the unique 'smell' of C. diff which would lead to rapid diagnosis of the condition. What is more, the Leicester team say it could be possible to identify different...

2014-09-02 08:29:18

-- Company Completes Final Preclinical Toxicology Study and Prepares to File Investigational New Drug (IND) in 2H 2014 -- ROCKVILLE, Md., Sept. 2, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today positive results from its final preclinical toxicology study of SYN-004. Per U.S. Food and Drug Administration (FDA)...

2014-08-28 08:27:37

-- Fujifilm's pAVEway(TM) Platform Demonstrated >25-fold Improvement in SYN-004 Expression Titers -- ROCKVILLE, Md., Aug. 28, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and FUJIFILM Diosynth Biotechnologies UK Limited (Fujifilm), announced today confirmation of exceptional results from the initial phase of cGMP manufacturing of...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'